Abstract
Tissue engineering, as a frontier of medicine, is aimed at regeneration of tissue and organ which can be used for the therapy of many diseases, such as trauma, cancer, and deformity. Some pluripotent stem cells are considered to be suitable for seed cells for tissue engineering, for example, bone marrow mesenchymal stem cells, adipose-derived stem cells and epidermal stem cells. Urine-derived stem cells (USCs) have been reported, and regarded as a candidate for seed cells in tissue engineering because of low-cost collection and isolation, efficient proliferation, and multidifferentiation potential, which have been documented in recent years. In this paper, we will introduce the biological characteristics of USCs and their potential applications in tissue engineering.
Keywords: Application on cell-based therapy, identification, multi-differentiation potential, tissue engineering, urine-derived stem cells.
Current Stem Cell Research & Therapy
Title:Urine-derived Stem Cells, A New Source of Seed Cells for Tissue Engineering
Volume: 11 Issue: 7
Author(s): Peng Gao, Dapeng Jiang, Wenjuan Liu, Huaining Li and Zhaozhu Li
Affiliation:
Keywords: Application on cell-based therapy, identification, multi-differentiation potential, tissue engineering, urine-derived stem cells.
Abstract: Tissue engineering, as a frontier of medicine, is aimed at regeneration of tissue and organ which can be used for the therapy of many diseases, such as trauma, cancer, and deformity. Some pluripotent stem cells are considered to be suitable for seed cells for tissue engineering, for example, bone marrow mesenchymal stem cells, adipose-derived stem cells and epidermal stem cells. Urine-derived stem cells (USCs) have been reported, and regarded as a candidate for seed cells in tissue engineering because of low-cost collection and isolation, efficient proliferation, and multidifferentiation potential, which have been documented in recent years. In this paper, we will introduce the biological characteristics of USCs and their potential applications in tissue engineering.
Export Options
About this article
Cite this article as:
Gao Peng, Jiang Dapeng, Liu Wenjuan, Li Huaining and Li Zhaozhu, Urine-derived Stem Cells, A New Source of Seed Cells for Tissue Engineering, Current Stem Cell Research & Therapy 2016; 11 (7) . https://dx.doi.org/10.2174/1574888X10666150220161506
DOI https://dx.doi.org/10.2174/1574888X10666150220161506 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine Microarrays and Colon Cancer in the Road for Translational Medicine
Current Bioinformatics Tetrapyrrolic Macrocycles: Potentialities in Medical Imaging Technologies
Current Organic Synthesis Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry Prediction by Pharmacogenetics of Safety and Efficacy of Non-Steroidal Anti- Inflammatory Drugs: A Review
Current Drug Metabolism Epivention: Epigenetic Based Cancer Chemoprevention
Epigenetic Diagnosis & Therapy (Discontinued) Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges
Current Topics in Medicinal Chemistry Cellular Therapy for Treatment of Stress Urinary Incontinence
Current Stem Cell Research & Therapy Synthesis and Applications of Hydrogels in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Non-diabetic Glucose levels and Cancer Mortality: A Literature Review
Current Diabetes Reviews MicroRNA-203: Tumor Suppression and Beyond
MicroRNA Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Current Cancer Drug Targets Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets